Drug Donanemab Offers New Hope in Dementia Fight

A new drug, Donanemab, is being hailed as a turning point in the fight against Alzheimer’s, after a global trial confirms it slows cognitive decline. The antibody medicine helps in the early stages of the disease by clearing a protein that builds up in the brains of people with this type of dementia. Although not a cure, charities say the results in the journal JAMA mark a new era where Alzheimer’s can be treated.

Read More

See for Yourself

The Cordwainer Names Erica Lathrop Sales Director

Schedule your in-person tour to see this lovely new community!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.